Is @entity633 a XXXX risk equivalent for atherothrombotic events?

@entity1 @entity8 @entity633 @entity1011 @entity583
OBJECTIVE: @entity1 with chronic @entity8 frequently experience cardiovascular events. This study sought to investigate whether the presence of @entity633 displays a vascular risk equivalent to that in @entity1 with prior @entity583 . METHODS: @entity633 was defined as a urinary albumin to @entity1011 ratio of 30   g/mg or greater in 852 consecutive @entity1 undergoing coronary angiography. Prospectively, we recorded vascular events over 3.2      1.2 years. RESULTS: From our @entity1 , 513 (60.2%) had neither @entity633 nor a history of MI, 126 (14.8%) had @entity633 without prior MI, 137 (16.1%) did not have @entity633 but had a history of MI, and 76 (8.9%) had both, @entity633 and prior MI. Compared with the incidence of the composite endpoint among normoalbuminuric @entity1 with no prior MI (11.9%), event rates nearly doubled both in @entity1 with @entity633 without prior MI (24.6%; p  =  0.003) and in normoalbuminuric @entity1 with a history of prior MI (21.2%; p  =  0.004) and were highest in @entity1 with both, @entity633 and prior MI (36.8%; p  <  0.001). Importantly, event rates were not significantly different between @entity1 with @entity633 and no prior history of MI and those with normoalbuminuria but prior MI (p  =  0.972). Moreover, the event rate in @entity1 with both, @entity633 and history of MI, was significantly higher (p  <  0.05) than in the two groups exhibiting only one of the two conditions. CONCLUSION: This is the first study demonstrating that @entity633 is a CAD risk equivalent. Thus, cardiovascular risk factors in albuminuric @entity1 should be treated as aggressively as in @entity1 with prior MI.
